Joachim Hasenmaier

Joachim Hasenmaier

Director/Board Member chez ECO ANIMAL HEALTH GROUP PLC

64 ans
Health Technology
Consumer Services
Finance

Profil

Joachim Alfred Hasenmaier is currently the Chairman at IMV Technologies SAS, a Non-Executive Director at ECO Animal Health Group Plc, a Director at Minotaur Ltd., and a Director at Invetx, Inc. Previously, he served as the Director-Animal Health & Consumer Healthcare at Boehringer Ingelheim GmbH, an Independent Director at Heska Corp., the Managing Director at C.H.
Boehringer Sohn AG & Co. KG, a Director at Boehringer Ingelheim RCV GmbH & Co. KG, the Co-Managing Director at Boehringer Ingelheim Vetmedica GmbH, and the Senior Vice President at Boehringer Ingelheim Animal Health GmbH.
He holds a doctorate from Ludwig-Maximilians-Universität München and an MBA from Kellogg School of Management.

Postes actifs de Joachim Hasenmaier

SociétésPosteDébut
ECO ANIMAL HEALTH GROUP PLC Director/Board Member 12/02/2024
Director/Board Member 06/01/2021
Chairman 01/01/2022
Director/Board Member -
Tous les postes actifs de Joachim Hasenmaier

Anciens postes connus de Joachim Hasenmaier

SociétésPosteFin
HESKA CORPORATION Director/Board Member 13/06/2023
Corporate Officer/Principal 01/01/2019
Corporate Officer/Principal 15/03/2018
Boehringer Ingelheim Animal Health GmbH Corporate Officer/Principal -
Chief Executive Officer -
Voir l'expérience en détail de Joachim Hasenmaier

Formation de Joachim Hasenmaier

Ludwig-Maximilians-Universität München Doctorate Degree
Kellogg School of Management Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Joachim Hasenmaier

Relations

35

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
ECO ANIMAL HEALTH GROUP PLC

Health Technology

Entreprise privées9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Boehringer Ingelheim Animal Health GmbH

Health Technology

Finance

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Joachim Hasenmaier